医药生物行业资金流出榜：恒瑞医药、康美药业等净流出资金居前

Market Overview - The Shanghai Composite Index rose by 0.59% on December 10, with 23 out of the 28 sectors experiencing gains, led by retail and beauty care sectors, which increased by 2.54% and 2.25% respectively [1] - The sectors that saw declines included utilities and oil & gas, with decreases of 0.74% and 0.47% respectively [1] Capital Flow Analysis - The main capital flow showed a net outflow of 33.974 billion yuan across the two markets, with only four sectors experiencing net inflows [1] - The food and beverage sector had the highest net inflow, totaling 2.14% in growth and 2.364 billion yuan in net inflow, followed by the retail sector with a 2.54% increase and a net inflow of 1.652 billion yuan [1] Pharmaceutical and Biological Sector - The pharmaceutical and biological sector closed flat, with a net outflow of 4.394 billion yuan, comprising 475 stocks, of which 215 rose and 239 fell [2] - Among the stocks in this sector, 161 experienced net inflows, with five stocks receiving over 50 million yuan, led by Aier Eye Hospital with a net inflow of 140 million yuan, followed by Fudan-Zhangjiang and Changshan Pharmaceutical with inflows of 124 million yuan and 100 million yuan respectively [2] - The sector also saw significant outflows, with seven stocks experiencing net outflows exceeding 100 million yuan, led by Hengrui Medicine, Kangmei Pharmaceutical, and Dezhan Health with outflows of 888 million yuan, 752 million yuan, and 191 million yuan respectively [2]